Overview

Pharmacological Treatment for Alcoholism

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn whether ondansetron is safe and effective in the treatment of alcohol dependence. We also want to learn whether the study drug ondansetron combined with Cognitive Behavioral Therapy will assist researchers to determine whether having a certain gene is responsible for determining how a person benefits or does not benefit from the use of ondansetron for alcohol dependence.
Phase:
Phase 3
Details
Lead Sponsor:
Bankole Johnson
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Treatments:
Ondansetron